Loading...
Grand Pharmaceutical Group Limited
0512.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$0.07(0.98%)
Hong Kong Market opens in 4h 58mGrand Pharmaceutical Group Limited (0512.HK) AI-Powered Stock Analysis
See how Grand Pharmaceutical Group Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerGrand Pharmaceutical Group Limited (0512.HK) Stock Overall Grade
Grand Pharmaceutical Group Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Grand Pharmaceutical Group Limited's overall stock rating.
Forecast
BScore
67/100Financial Growth
BScore
60/100Fundamental Growth
BScore
68/100Key Ratios
B+Score
76/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
96/100Analyst Consensus
C+Score
50/100Grand Pharmaceutical Group Limited (0512.HK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 67/100 (B), reflecting high confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (68/100, B) highlight its stability, while Key Ratios (76/100, B+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (96/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Grand Pharmaceutical Group Limited stock grade, including financials, comparisons, and forecasts.